קסנזין 25 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

TETRABENAZINE 25 MG

MAH:

MEGAPHARM LTD

ATC_code:

N07XX06

pharmaceutical_form:

TABLETS

administration_route:

PER OS

manufactured_by:

LIFEHEALTH LIMITED, UK

therapeutic_group:

TETRABENAZINE

therapeutic_indication:

Movement disorders, associated with organic central nervous system conditions, e.g. Huntington's chorea, hemiballismus and senile chorea.Moderate to severe tardive dyskinesia, which is disabling and/or socially embanassing. The condition should be persistent despite a switch to atypical antipsychotic medication and/or reduction in dosage of antipsychotic medication, when withdrawal of antipsychotic medication is not a realistic option.

authorization_date:

2009-11-01